Frontlight ResearchEarly access
Trial site
Clinical Research of Osceola
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Crohn's disease2 trials
- Irritable bowel syndrome1 trial
- Phase
- Phase 25 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Gilead Sciences1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- Takeda1 trial
Running trials
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis2 recruiting
- Crohn's disease1 recruiting
- Irritable bowel syndrome1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026